Investor Relations

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair.